Phoenix Biotech Acquisition Corp. announced a private placement of non-convertible promissory note for gross proceeds of $1,500,000 on December 16, 2022. The transaction includes participation from Phoenix Biotech Sponsor, LLC.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | +8.97% | -2.90% | -90.91% |
1st Jan change | Capi. | |
---|---|---|
-90.91% | 13.51M | |
+9.91% | 118B | |
+10.27% | 106B | |
-11.95% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.93% | 15.97B | |
+6.30% | 14.03B | |
+16.22% | 11.67B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- Phoenix Biotech Acquisition Corp. announced that it expects to receive $1.5 million in funding